proxyvotesnow.com

Home › Companies › ORTHOPEDIATRICS CORP. › 2023-2024

ORTHOPEDIATRICS CORP. 2023-2024 Proxy Voting Records

Compiled from SEC Form N-PX filings and ORTHOPEDIATRICS CORP.’s Form 8-K, filed 2024-05-28 (Item 5.07 on EDGAR). Page generated 04 October 2026.

  • 8Reported items
  • 177Asset managers
  • 1,143Fund votes
  • 2024-05-24Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore ORTHOPEDIATRICS CORP. in the interactive database Compare manager voting policies

Official 2023-2024 meeting results reported by ORTHOPEDIATRICS CORP.

These tallies are ORTHOPEDIATRICS CORP.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2024-05-28 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

ORTHOPEDIATRICS CORP. — official shareholder meeting results, meeting held 2024-05-24
Ballot itemForAgainst AbstainWithheldBroker non-votesOutcome
Elect Director: David R. Bailey 18,199,037---- 1,790,600727,703 Majority: yes
Elect Director: Marie C. Infante 12,686,531---- 7,186,996843,813 Majority: yes
Elect Director: Jimmy D. McDonald 14,265,857---- 5,721,728729,755 Majority: yes
Approval of the OrthoPediatrics Corp. 2024 Incentive Award Plan The Company's stockholders approved the OrthoPediatrics Corp. 18,409,9071,279,054305,167 --723,212 Majority: yes

Source: ORTHOPEDIATRICS CORP., Form 8-K, filed with the SEC on 2024-05-28 — read the filing on EDGAR.

How asset managers voted at the ORTHOPEDIATRICS CORP. 2023-2024 meeting

Each item below shows how the 177 asset managers that disclosed a ORTHOPEDIATRICS CORP. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of ORTHOPEDIATRICS CORP.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. To approve, on an advisory basis, the compensation of our named executive officers.

SECTION 14A SAY-ON-PAY VOTESCOMPENSATION

Combines 4 wordings of this item as funds reported it.

99% fund support · no official result

FOR 99%

The 130 asset managers below cast 99% of the shares they voted on this item FOR (13,044,421 for, 179,175 against).

FOR: 13,044,421 (98.6%)AGAINST: 179,175 (1.4%)NOT VOTED: 34 (0.0%)
Largest asset managers voting on “To approve, on an advisory basis, the compensation of our named executive officers.” at ORTHOPEDIATRICS CORP., 2023-2024
Asset managerForAgainst AbstainWithheldVote
BROWN CAPITAL MANAGEMENT LLC1,673,4890 00For
BROWN ADVISORY INC1,411,1175,802 00For
Brown Capital Management Mutual Funds1,220,1410 00For
BRAIDWELL LP1,019,4900 00For
Vanguard885,4030 00For
BlackRock789,4724,608 00For
Wellington656,4000 00For
Granahan Investment Management, LLC572,6840 00For
NEW YORK STATE COMMON RETIREMENT FUND561,8960 00For
State Street488,423596 00For
WASATCH ADVISORS LP452,1360 00For
Dimensional386,1660 00For
GEODE CAPITAL MANAGEMENT, LLC367,8180 00For
Fidelity355,9830 00For
WASATCH FUNDS TRUST351,2260 00For
Charles Schwab272,5780 00For
Principal188,8260 00For
Goldman Sachs128,2600 00For
NEXT CENTURY GROWTH INVESTORS LLC108,4860 00For
KENNEDY CAPITAL MANAGEMENT LLC75,00114,610 00For
UBS66,09713,276 00For
Victory Capital78,7490 00For
PARAMETRIC PORTFOLIO ASSOCIATES LLC73,7000 00For
MELLON INVESTMENTS Corp065,710 00Against
Nationwide64,9520 00For

Showing the 25 largest of 130 asset managers. See all 130 in the interactive database.

2. To elect three (3) directors, each to serve until the 2027 annual meeting of our stockholders: David R. Bailey

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

91% Majority: yes · of votes cast

FOR 91%9%
FOR: 18,199,037WITHHELD: 1,790,600

ORTHOPEDIATRICS CORP.’s own tally for this item (“Elect Director: David R. Bailey”): 18,199,037 for, 1,790,600 withheld, per its Form 8-K filed 2024-05-28 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 23,828,882 outstanding shares: 76% for, 8% withheld (84% of the company cast a for/withheld vote).

The 59 asset managers below cast 100% of the shares they voted on this item FOR (5,049,623 for, 0 against).

FOR 94%
FOR: 5,049,623 (93.6%)ABSTAIN: 345,635 (6.4%)
Largest asset managers voting on “To elect three (3) directors, each to serve until the 2027 annual meeting of our stockholders: David R. Bailey” at ORTHOPEDIATRICS CORP., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Brown Capital Management Mutual Funds1,220,1410 00For
Vanguard846,2120 00For
Brown Advisory Funds508,7290 00For
Fidelity354,9890 00For
WASATCH FUNDS TRUST351,2260 00For
Dimensional00 331,3060Abstain
BlackRock298,2750 00For
Jackson National195,2250 6,5090For
Principal188,8260 00For
Charles Schwab124,4280 00For
PARADIGM FUNDS119,4000 00For
Goldman Sachs102,7720 00For
State Street92,6000 5630For
Victory Capital76,6770 00For
Nationwide64,9520 00For
Royce55,6230 00For
New York Life52,4930 00For
Equitable41,1650 00For
MoA Funds Corp38,0390 00For
TIAA37,0460 00For
QUANTITATIVE MASTER SERIES LLC29,6090 00For
BUFFALO FUNDS28,4900 00For
CLEARWATER INVESTMENT TRUST28,0870 00For
PACE SELECT ADVISORS TRUST22,4780 00For
Harbor Funds II18,7750 00For

Showing the 25 largest of 59 asset managers. See all 59 in the interactive database.

3. To elect three (3) directors, each to serve until the 2027 annual meeting of our stockholders: Jimmy D. McDonald

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

71% Majority: yes · of votes cast

FOR 71%WITHHELD 29%
FOR: 14,265,857WITHHELD: 5,721,728

ORTHOPEDIATRICS CORP.’s own tally for this item (“Elect Director: Jimmy D. McDonald”): 14,265,857 for, 5,721,728 withheld, per its Form 8-K filed 2024-05-28 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 23,828,882 outstanding shares: 60% for, 24% withheld (84% of the company cast a for/withheld vote).

The 59 asset managers below cast 100% of the shares they voted on this item FOR (3,758,529 for, 0 against).

FOR 70%ABSTAIN 30%
FOR: 3,758,529 (69.7%)ABSTAIN: 1,636,729 (30.3%)
Largest asset managers voting on “To elect three (3) directors, each to serve until the 2027 annual meeting of our stockholders: Jimmy D. McDona” at ORTHOPEDIATRICS CORP., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Brown Capital Management Mutual Funds1,220,1410 00For
Vanguard846,2120 00For
Brown Advisory Funds00 508,7290Abstain
Fidelity354,9890 00For
WASATCH FUNDS TRUST351,2260 00For
Dimensional00 331,3060Abstain
BlackRock298,2750 00For
Jackson National00 201,7340Abstain
Principal00 188,8260Abstain
Charles Schwab124,4280 00For
PARADIGM FUNDS119,4000 00For
Goldman Sachs00 102,7720Abstain
State Street91,5890 1,5740For
Victory Capital00 76,6770Abstain
Nationwide60,8550 4,0970For
Royce55,6230 00For
New York Life00 52,4930Abstain
Equitable41,1650 00For
MoA Funds Corp00 38,0390Abstain
TIAA00 37,0460Abstain
QUANTITATIVE MASTER SERIES LLC29,6090 00For
BUFFALO FUNDS28,4900 00For
CLEARWATER INVESTMENT TRUST28,0870 00For
PACE SELECT ADVISORS TRUST22,4780 00For
Harbor Funds II18,7750 00For

Showing the 25 largest of 59 asset managers. See all 59 in the interactive database.

4. To elect three (3) directors, each to serve until the 2027 annual meeting of our stockholders: Marie C. Infante

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

64% Majority: yes · of votes cast

FOR 64%WITHHELD 36%
FOR: 12,686,531WITHHELD: 7,186,996

ORTHOPEDIATRICS CORP.’s own tally for this item (“Elect Director: Marie C. Infante”): 12,686,531 for, 7,186,996 withheld, per its Form 8-K filed 2024-05-28 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 23,828,882 outstanding shares: 53.2% for, 30% withheld (83% of the company cast a for/withheld vote).

The 59 asset managers below cast 100% of the shares they voted on this item FOR (3,116,656 for, 0 against).

FOR 58%ABSTAIN 42%
FOR: 3,116,656 (57.8%)ABSTAIN: 2,278,602 (42.2%)
Largest asset managers voting on “To elect three (3) directors, each to serve until the 2027 annual meeting of our stockholders: Marie C. Infant” at ORTHOPEDIATRICS CORP., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Brown Capital Management Mutual Funds1,220,1410 00For
Vanguard846,2120 00For
Brown Advisory Funds00 508,7290Abstain
Fidelity346,4160 8,5730For
WASATCH FUNDS TRUST351,2260 00For
Dimensional00 331,3060Abstain
BlackRock00 298,2750Abstain
Jackson National00 201,7340Abstain
Principal00 188,8260Abstain
Charles Schwab00 124,4280Abstain
PARADIGM FUNDS119,4000 00For
Goldman Sachs00 102,7720Abstain
State Street5150 92,6480Abstain
Victory Capital00 76,6770Abstain
Nationwide60,8550 4,0970For
Royce55,6230 00For
New York Life00 52,4930Abstain
Equitable00 41,1650Abstain
MoA Funds Corp00 38,0390Abstain
TIAA00 37,0460Abstain
QUANTITATIVE MASTER SERIES LLC00 29,6090Abstain
BUFFALO FUNDS28,4900 00For
CLEARWATER INVESTMENT TRUST28,0870 00For
PACE SELECT ADVISORS TRUST22,4780 00For
Harbor Funds II18,7750 00For

Showing the 25 largest of 59 asset managers. See all 59 in the interactive database.

5. To approve the Company's 2024 Incentive Award Plan.

COMPENSATIONMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

94% Majority: yes · of votes cast

FOR 94%
FOR: 18,409,907AGAINST: 1,279,054

ORTHOPEDIATRICS CORP.’s own tally for this item (“Approval of the OrthoPediatrics Corp. 2024 Incentive Award Plan The Company's stockholders approved the OrthoPediatrics Corp.”): 18,409,907 for, 1,279,054 against, per its Form 8-K filed 2024-05-28 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 23,828,882 outstanding shares: 77% for, 5% against (83% of the company cast a for/against vote).

The 58 asset managers below cast 97% of the shares they voted on this item FOR (5,135,377 for, 140,481 against).

FOR 97%
FOR: 5,135,377 (97.3%)AGAINST: 140,481 (2.7%)
Largest asset managers voting on “To approve the Company's 2024 Incentive Award Plan.” at ORTHOPEDIATRICS CORP., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Brown Capital Management Mutual Funds1,220,1410 00For
Vanguard846,2120 00For
Brown Advisory Funds508,7290 00For
Fidelity354,9890 00For
WASATCH FUNDS TRUST351,2260 00For
Dimensional331,3060 00For
BlackRock298,2750 00For
Jackson National201,7340 00For
Principal188,8260 00For
Charles Schwab0124,428 00Against
Goldman Sachs102,7720 00For
State Street92,672491 00For
Victory Capital76,6770 00For
Nationwide64,9520 00For
Royce55,6230 00For
New York Life52,4930 00For
Equitable41,1650 00For
MoA Funds Corp38,0390 00For
TIAA37,0460 00For
QUANTITATIVE MASTER SERIES LLC29,6090 00For
BUFFALO FUNDS28,4900 00For
CLEARWATER INVESTMENT TRUST28,0870 00For
PACE SELECT ADVISORS TRUST22,4780 00For
Harbor Funds II18,7750 00For
Lincoln Financial14,8890 00For

Showing the 25 largest of 58 asset managers. See all 58 in the interactive database.

6. To approve, on an advisory basis, the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2024.

AUDIT-RELATED

Combines 2 wordings of this item as funds reported it.

99.9% fund support · no official result

FOR 99.9%

The 58 asset managers below cast 99.9% of the shares they voted on this item FOR (5,275,367 for, 491 against).

FOR: 5,275,367 (100.0%)AGAINST: 491 (0.0%)
Largest asset managers voting on “To approve, on an advisory basis, the appointment of Deloitte & Touche LLP as our independent registered publi” at ORTHOPEDIATRICS CORP., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Brown Capital Management Mutual Funds1,220,1410 00For
Vanguard846,2120 00For
Brown Advisory Funds508,7290 00For
Fidelity354,9890 00For
WASATCH FUNDS TRUST351,2260 00For
Dimensional331,3060 00For
BlackRock298,2750 00For
Jackson National201,7340 00For
Principal188,8260 00For
Charles Schwab124,4280 00For
Goldman Sachs102,7720 00For
State Street92,672491 00For
Victory Capital76,6770 00For
Nationwide64,9520 00For
Royce55,6230 00For
New York Life52,4930 00For
Equitable41,1650 00For
MoA Funds Corp38,0390 00For
TIAA37,0460 00For
QUANTITATIVE MASTER SERIES LLC29,6090 00For
BUFFALO FUNDS28,4900 00For
CLEARWATER INVESTMENT TRUST28,0870 00For
PACE SELECT ADVISORS TRUST22,4780 00For
Harbor Funds II18,7750 00For
Lincoln Financial14,8890 00For

Showing the 25 largest of 58 asset managers. See all 58 in the interactive database.

7. To approve, on an advisory basis, the compensation of our executive officers who are named in the compensation disclosures in the accompanying Proxy Statement

SECTION 14A SAY-ON-PAY VOTES

Combines 2 wordings of this item as funds reported it.

99.9% fund support · no official result

FOR 99.9%

The 46 asset managers below cast 99.9% of the shares they voted on this item FOR (1,557,653 for, 1,205 against).

FOR: 1,557,653 (99.9%)AGAINST: 1,205 (0.1%)
Largest asset managers voting on “To approve, on an advisory basis, the compensation of our executive officers who are named in the compensation” at ORTHOPEDIATRICS CORP., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Brown Advisory Funds508,7290 00For
RIVERBRIDGE PARTNERS LLC363,9530 00For
Jackson National201,7340 00For
Prosight Management, LP167,5830 00For
Northern Trust143,43512 00For
Conestoga Capital Advisors, LLC48,6790 00For
BUFFALO FUNDS28,4900 00For
Harbor Funds II18,7750 00For
JPMorgan11,6520 00For
ENVESTNET ASSET MANAGEMENT INC6,8450 00For
Indiana Trust & Investment Management CO6,7650 00For
WILSHIRE MUTUAL FUNDS INC6,5850 00For
John Hancock5,9350 00For
DF DENT & CO INC5,7500 00For
NORDEN GROUP LLC5,7500 00For
CONESTOGA FUNDS5,0840 00For
Allianz3,9720 00For
Bridge Builder Trust3,3090 00For
OPPENHEIMER ASSET MANAGEMENT INC.2,9720 00For
US BANK NATIONAL ASSOCIATION2,6240 00For
First Trust2,5730 00For
Perfromance Wealth Partners, LLC2,0000 00For
PNC BANK, NATIONAL ASSOCIATION1,2680 00For
VILLERE ST DENIS J & CO LLC1,1000 00For
XPONANCE, INC.0818 00Against

Showing the 25 largest of 46 asset managers. See all 46 in the interactive database.

8. Advisory Vote to Ratify Named Executive Officers' Compensation

SECTION 14A SAY-ON-PAY VOTES

100% fund support · no official result

FOR 100%

The 3 asset managers below cast 100% of the shares they voted on this item FOR (126,377 for, 0 against).

FOR: 126,377 (100.0%)
Largest asset managers voting on “Advisory Vote to Ratify Named Executive Officers' Compensation” at ORTHOPEDIATRICS CORP., 2023-2024
Asset managerForAgainst AbstainWithheldVote
PARADIGM FUNDS119,4000 00For
JPMorgan5,9290 00For
PARADIGM CAPITAL MANAGEMENT INC/NY1,0480 00For

Largest ORTHOPEDIATRICS CORP. shareholders voting in 2023-2024

Ranked by the number of ORTHOPEDIATRICS CORP. shares each manager voted on the most widely held ballot item of the 2023-2024 meeting, shown as a share of the 23,828,882 shares outstanding at the time of that meeting.

Top ORTHOPEDIATRICS CORP. shareholders by shares voted, 2023-2024
#Asset manager % of shares outstanding
1BROWN CAPITAL MANAGEMENT LLC 7.02%
2BROWN ADVISORY INC 5.95%
3Brown Capital Management Mutual Funds 5.12%
4BRAIDWELL LP 4.28%
5Vanguard 3.72%
6BlackRock 3.33%
7Wellington 2.75%
8Granahan Investment Management, LLC 2.40%
9NEW YORK STATE COMMON RETIREMENT FUND 2.36%
10State Street 2.05%

Reported ORTHOPEDIATRICS CORP. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

ORTHOPEDIATRICS CORP. beneficial owners on record for the 2023-2024 proxy season
Holder % outstanding Disclosure
David R. Pelizzon 29.06% DEF14A
Squadron Capital LLC 28.96% DEF14A
Brown Capital Management, LLC 13.93% DEF14A
Brown Advisory Incorporated 6.80% DEF14A
BlackRock 5.11% 13F
Morgan Stanley 4.66% 13F
Vanguard Group 4.03% 13F
Dimensional Fund Advisors 2.13% 13F
State Street 1.82% 13F
Geode Capital 1.54% 13F

Percentages above are of 23,828,882 shares outstanding, as reported by ORTHOPEDIATRICS CORP. on its Form 10-Q dated 2024-05-03 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from ORTHOPEDIATRICS CORP.’s 10-Q dated 2024-05-03. This page is a static snapshot rebuilt weekly on 04 October 2026; a live search always shows the current data.

At ORTHOPEDIATRICS CORP.'s shareholder meeting held 2024-05-24, in the 2023-2024 proxy season, 177 asset managers reported how they voted in their SEC Form N-PX filings, covering 1,143 separate fund positions. Their filings are grouped here into 8 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. ORTHOPEDIATRICS CORP.'s own Form 8-K tally for this meeting is published below, but no row in it could be matched to the most widely held item, so this page states no certified outcome for that item. On that item — To approve, on an advisory basis, the compensation of our named executive officers. — the reporting funds cast 99% of the shares they voted in favour (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). That is the aggregate of those managers' own N-PX disclosures, not the company's certified result, and the funds are a subset of all shareholders.

ORTHOPEDIATRICS CORP. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.